Free Trial
→ The Standard Oil of AI? (From Behind the Markets) (Ad)

10 Best Penny Stocks to Buy Now - 6 of 10

Slide 6
Back to 5
Continue to 7
 
Back to 5
Continue to 7
 

bluebird bio (NASDAQ:BLUE)

Number of Upgrades from Top-Ranked Analysts
3 (in the last 90 days)
Consensus Rating
Hold
Rating Score
2.3
Ratings Breakdown
4 Buy Ratings, 7 Hold Ratings, 1 Sell Ratings.
Consensus Price Target
$4.63 (791.9% Upside)

About bluebird bio

bluebird bio logobluebird bio, Inc, a biotechnology company, researches, develops, and commercializes gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include ZYNTEGLO (betibeglogene autotemcel) for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell disease (SCD); and SKYSONA (elivaldogene autotemcel) to treat cerebral adrenoleukodystrophy. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
9/25/2024Wells Fargo & CompanyLower Price TargetEqual Weight ➝ Equal Weight$3.00 ➝ $2.00
9/16/2024Cantor FitzgeraldReiterated RatingNeutral
8/15/2024Bank of AmericaLower Price TargetBuy ➝ Buy$4.00 ➝ $3.00
8/15/2024Royal Bank of CanadaReiterated RatingSector Perform ➝ Sector Perform$4.00 ➝ $4.00
8/15/2024BarclaysLower Price TargetOverweight ➝ Overweight$8.00 ➝ $4.00
8/15/2024Robert W. BairdLower Price TargetOutperform ➝ Outperform$7.00 ➝ $6.00
8/15/2024JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral
3/27/2024Royal Bank of CanadaReiterated RatingSector Perform ➝ Sector Perform$6.00
3/27/2024Wells Fargo & CompanyLower Price TargetEqual Weight ➝ Equal Weight$4.00 ➝ $3.00
3/19/2024WedbushLower Price TargetNeutral ➝ Neutral$1.72 ➝ $1.68
Slide 6
Back to 5
Continue to 7
 

Revolutionary Tech Alert: How Elon Musk is Changing Lives (Ad)

"Elon Musk's Neuralink just received FDA breakthrough status for a revolutionary device designed to restore vision to those who've lost it entirely. And the first human clinical trials have opened for recruitment.

Click here to see it.

More From MarketBeat
[Urgent!] Web3 Could Send One Crypto Soaring
Venture Capital corporations and blockchain funds are pouring money into Web3 gaming. And there's one littl...
Crypto 101 Media | Sponsored
7 Energy Stocks with Attractive High-Yield Dividends
With interest rates likely to move lower starting with the Federal Reserve's September meeting, many investors...
MarketBeat
Elon Musk’s chilling warning for humanity
The 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...
The Freeport Society | Sponsored
20 Stocks Wall Street Analysts Love the Most
Every trading day, between 500 and 800 new recommendations and research reports are issued by sell-side equiti...
MarketBeat
Grab this ETF paying a huge 22% dividend
Imagine a world where you don't have to stress about inflation eroding your savings... Where your paycheck ...
Investors Alley | Sponsored
7 Downgraded Stocks That Still May Be Worth a Look
A key reason a stock price drops is one or more analyst downgrades. An analyst typically downgrades a stock be...
MarketBeat